德语，英语，法语，意大利语

姓名

职能

电子邮件

1. Rüttimann S, Bonetti P, Beglinger C, Loosli J, Meyer-Wyss B, Stalder GA, Dubach UC. Is flexible sigmoidoscopy as preventive measure for colorectal carcinoma in asymptomatic patients over 45 practicable? Schweizerische Medizinische Wochenschrift
   1992;122:742-4.
2. Bonetti PO, Hartmann K, Kuhn M, Reinhart WH, Wieland T. Potential drug interactions and incidence of prescriptions necessitating special instructions after discharge from hospital. Schweiz Med Rundsch Praxis
   2000;89:182-9.
3. Bonetti PO, Waeckerlin A, Schuepfer G, Frutiger A. Improving time-sensitive processes in the intensive care unit: The example of „door-to-needle time„ in acute myocardial infarction. Int J Qual Health Care
   2000;12:311-7.
4. Dubach P, Myers J, Bonetti P, Schertler T, Froelicher V, Wagner D, Scheidegger M, Stuber M, Luchinger R, Schwitter J, Hess O. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging. Am Heart J
   2002;143:676-83.
5. Bonetti PO, Wilson SH, Rodriguez-Porcel M, Holmes DR Jr, Lerman LO, Lerman A. Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering. J Am Coll Cardiol
   2002;40:546-54.
6. Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, Schnall RP, Holmes DR Jr, Higano ST, Lerman A. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol
   2003;41:1761-8.
7. Targonski PV*, Bonetti PO* Pumper GM, Higano ST, Holmes DR Jr, Lerman A. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation
   2003;107:2805-9.
8. Bonetti PO, Best PJM, Rodriguez-Porcel M, Holmes DR Jr, Lerman LO, Lerman A. Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemia. Atherosclerosis 2003; 168:367-73.
9. Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol
   2004;44:2137-41.
10. Bonetti PO, Gadasalli SN, Lerman A, Barsness GW. Successful treatment of symptomatic coronary endothelial dysfunction with enhanced external counterpulsation. Mayo Clin Proc
    2004;79:690-2.
11. Bonetti PO, Kaiser C, Zellweger MJ, Grize L, Erne P, Schoenenberger RA, Pfisterer ME. Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease. J Cardiovasc Pharmacol Ther
    2005;10:29-37.
12. Jeger RV, Bonetti PO, Zellweger MJ, Tobler D, Kaiser CA, Osswald S, Buser PT, Pfisterer ME and the TIME Investigators. Influence of revascularization on long-term outcome in patients 75 years of age with diabetes mellitus and angina pectoris. Am J Cardiol
    2005;96:193-8.
13. Kaiser C, Brunner-La Rocca HP, Buser PT, Bonetti PO, Osswald S, Linka A, Bernheim A, Zutter A, Zellweger M, Grize L, Pfisterer ME, for the BASKET Investigators. Incremental cost-effectiveness of drug-eluting stents compared to a new generation bare-metal stent in a real world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet
    2005;366:921-9.
14. Elesber AA*, Bonetti PO*, Woodrum JE, Zhu XY, Lerman LO, Younkin SG, Lerman A. Bosentan preserves endothelial function in mice overexpressing APP. Neurobiol Aging
    2006;27:446-50.
15. Pfisterer M, Bertel O, Bonetti PO, Brunner-La Rocca HP, Eberli FR, Erne P, Galatius S, Hornig B, Kiowski W, Pachinger O, Pedrazzini G, Rickli H, De Servi S, Kaiser C; BASKET-PROVE Investigators. Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design. Am Heart J
    2008;155:609-14.
16. Jeger RV, Schneiter S, Kaiser C, Bonetti PO, Brunner-La Rocca H, Handke M, Osswald S, Buser PT, Pfisterer ME. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not large native vessel inerventions. Cardiology
    2009;112:49-55.
17. Trachsel LD, Kuhn MU, Reinhart WH, Schulzki T, Bonetti PO. Reduced incidence of acute myocardial infarction in the first year after implementation of a public smoking ban in Graubuenden, Switzerland. Swiss Med Weekly 2010;140:133-8.
18. Lardi E, Ott C, Schulzki T, Kuhn M, Bonetti PO, Reinhart WH. Acute effects of short-term exposure to second-hand smoke on induced platelet aggregation. Clin Hemorheol Microcirc
    2010;45:359-64.
19. Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, Pedrazzini G, Hornig B, Bertel O, Bonetti P, De Servi S, Brunner-La Rocca H P, Richard I, Pfisterer M for the BASKET-PROVE Study Group. Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med
    2010;363:2310-9.
20. Bonetti PO, Lardi E, Geissmann C, Kuhn MU, Brüesch H, Reinhart WH. Effect of Brief Secondhand Smoke Exposure on Endothelial Function and Circulating Markers of Inflammation. Atherosclerosis
    2011;215:218-22.
21. Mannheim D, Herrmann J, Bonetti PO, Lavi R, Lerman LO, Lerman A. Simvastatin preserves diastolic function in experimental hypercholesterolemia independent of its lipid lowering effect. Atherosclerosis
    2011;216:283-91.
22. Sears O, Reinhart WH, Bonetti PO. Quality of lipid management in patients with a history of myocardial infarction in general practice in Graubuenden, Switzerland. Cardiovascular Medicine
    2011;14:152-8.
23. Bonetti PO, Trachsel LD, Kuhn MU, Schulzki T, Erne P, Radovanovic D, Reinhart WH. Incidence of acute myocardial infarction after implementation of a public smoking ban in Graubuenden, Switzerland: 2-year follow-up. Swiss Med Weekly
    2011;141:w13206.
24. Cricri P, Trachsel LD, Müller P, Wäckerlin A, Reinhart WH, Bonetti PO. Incidence and time frame of life-threatening arrhythmias in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Swiss Med Weekly
    2012;142:w13604.
25. Reinhart SA, Schulzki T, Bonetti PO, Reinhart WH. Studies on metabolically depleted erythrocytes. Clin Hemorheol Microcirc
    2014;56:161-73.
26. Jeger RV, Pfisterer ME, Sorensen R, von Felten S, Alber H, Bonetti PO, Eberli F, Erne P, Pedrazzini G, Rickli H, Galatius S, Kaiser CA for the BASKET and BASKET-PROVE investigators. Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations. Am Heart J
    2014;168:698-705.
27. Vassalli G, Klersy C, De Servi S, Galatius S, Erne P, Eberli F, Rickli H, Hornig B, Bertel O, Bonetti P, Moccetti T, Kaiser C, Pfisterer M, Pedrazzini G; BASKET-PROVE Investigators. Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial. Am Heart J 2016;173:1-7.

Fallberichte

1. Bonetti PO, Gadasalli SN, Lerman A, Barsness GW. Successful treatment of symptomatic coronary endothelial dysfunction with enhanced external counterpulsation. Mayo Clin Proc
   2004;79:690-2.
2. Bonetti PO, Gutmann M, Cron TA, Schaer B, Osswald S. Transient complete nodal atrioventricular block and left bundle branch block during radiofrequency catheter ablation of a left free wall accessory pathway. Kardiovaskuläre Medizin
   2005;8:324-9.
3. Gnehm P, Pfisterer ME, Bonetti PO. Differentiation between sinus bradycardia and second-degree atrioventricular block by left ventricular pressure tracing. Kardiovaskuläre Medizin
   2005;12:453.
4. Bonetti PO, Hunziker PR. Watching football on TV may potentially be life-threatening. Swiss Medical Weekly
   2006;136:228.
5. Fausch K, Dubach P, Reinhart W, Bonetti PO. Capecitabininduzierte Koronarspasmen: eine wenig bekannte, aber gefährliche Nebenwirkung. Schweiz Med Forum
   2007;7:544-5.
6. Fahrner-Muschietti R, Kern R, Fahrner B, Bonetti PO. Hypothyreose: eine kaum bekannte Ursache für ein verlängertes QT-Intervall. Schweiz Med Forum
   2008;8:663-4.
7. Laske A, Ritter M, Bonetti PO. Right coronary artery to coronary sinus fistula. Eur J Cardiothorac Surg 2009;36:1079-80.
8. Gerber B, Kyburz T, Reinhart WH, Bonetti PO, Stussi G. Complement inhibition to treat myocardial infarction? BMJ Case Reports 2011;doi:10.1136/bcr.01.
   2011.3701.
9. Nägele R, Bonetti PO, Mayer KA. A patient with pulmonary embolism and a mass in the left atrium. Heart 2012;98:1260.

评论文章

1. Bonetti PO, Pfisterer ME, Lerman A. Lipid-unabhängige Statineffekte – sind sie klinisch relevant? Kardiovaskuläre Medizin
   2002;5:249-56.
2. Bonetti PO, Holmes DR Jr, Lerman A, Barsness GW. Enhanced external counterpulsation for ischemic heart disease: What’s behind the curtain? J Am Coll Cardiol
   2003;41:1918-25.
3. Bonetti PO, Lerman LO, Napoli C, Lerman A. Statin effects beyond lipid lowering – are they clinically relevant?. Eur Heart J
   2003;24:225-48.
4. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction – a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol
   2003;23:168-75.
5. Kaufmann BA, Kaiser C, Pfisterer ME, Bonetti PO. Coronary stent infection: a rare but severe complication of percutaneous coronary intervention. Swiss Medical Weekly
   2005;135:483-7.
6. Kaiser CA, Bonetti PO, Pfisterer ME. Stellenwert der Koronarrevaskularisation bei älteren Patienten mit chronischer koronarer Herzkrankheit. Kardiovaskuläre Medizin
   2006;9:16-22.
7. Elesber AA, Bonetti PO, Lerman A. Endothelial function and cerebrovascular disease: implications for diagnosis and treatment. Curr Treat Options Cardiovasc Med
   2006;8:213-9.
8. Bonetti PO. Stabile Angina pectoris: Wer soll invasiv abgeklärt warden? Schweiz Med Forum
   2010;10:662-6.
9. Bonetti PO. Wichtige Stadieneinteilungen und Scores in der Kardiologie. Ther Umsch
   2013;70:581-8.

评论文章

1. Bonetti PO. Nonspecific placebo effects. In: Barsness G & Holmes DR, eds. Coronary Artery Disease: New Approaches without Traditional Revascularization. Springer, Surrey, UK. In press.
2. Bonetti PO, Zellweger MJ, Kaiser C, Pfisterer ME. Acute coronary syndrome in special groups of patients. In: Bertrand M & King S, eds. Acute Coronary Syndromes: a Handbook for Clinical Practice. Blackwell Publishing, Oxford UK.
3. Pfisterer M, Bonetti PO, Zellweger MJ, Kaiser C. Diagnostik und interventionelle Therapie der koronaren Herzkrankheit. In: Zerkowski HR & Baumann G, eds. HerzAkutMedizin. Steinkopff Verlag, Darmstadt.

书章

1. Bonetti PO. Nonspecific placebo effects. In: Barsness G & Holmes DR, eds. Coronary Artery Disease: New Approaches without Traditional Revascularization. Springer, Surrey, UK. In press.
2. Bonetti PO, Zellweger MJ, Kaiser C, Pfisterer ME. Acute coronary syndrome in special groups of patients. In: Bertrand M & King S, eds. Acute Coronary Syndromes: a Handbook for Clinical Practice. Blackwell Publishing, Oxford UK.
3. Pfisterer M, Bonetti PO, Zellweger MJ, Kaiser C. Diagnostik und interventionelle Therapie der koronaren Herzkrankheit. In: Zerkowski HR & Baumann G, eds. HerzAkutMedizin. Steinkopff Verlag, Darmstadt.